168 related articles for article (PubMed ID: 35469597)
1. Identification of patient characteristics associated with survival benefit from metformin treatment in patients with stage I non-small cell lung cancer.
Elkin PL; Mullin S; Tetewsky S; Resendez SD; McCray W; Barbi J; Yendamuri S
J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1318-1326.e3. PubMed ID: 35469597
[TBL] [Abstract][Full Text] [Related]
2. Association of Receipt of Positron Emission Tomography-Computed Tomography With Non-Small Cell Lung Cancer Mortality in the Veterans Affairs Health Care System.
Vella M; Meyer CS; Zhang N; Cohen BE; Whooley MA; Wang S; Hope MD
JAMA Netw Open; 2019 Nov; 2(11):e1915828. PubMed ID: 31747036
[TBL] [Abstract][Full Text] [Related]
3. Body Mass Index Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC.
Yendamuri S; Barbi J; Pabla S; Petrucci C; Punnanitinont A; Nesline M; Glenn ST; Depietro P; Papanicalou-Sengos A; Morrison C; Dy GK; Elkin PL
J Thorac Oncol; 2019 Dec; 14(12):2181-2187. PubMed ID: 31398539
[TBL] [Abstract][Full Text] [Related]
4. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
[TBL] [Abstract][Full Text] [Related]
6. Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.
Bhatt VR; Batra R; Silberstein PT; Loberiza FR; Ganti AK
Med Oncol; 2015 Jan; 32(1):339. PubMed ID: 25429831
[TBL] [Abstract][Full Text] [Related]
7. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
8. Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum.
Wen-Xiu X; Xiao-Wei Z; Hai-Ying D; Ying-Hui T; Si-Si K; Xiao-Fang Z; Huang P
Medicine (Baltimore); 2018 Dec; 97(51):e13652. PubMed ID: 30572481
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with stage IV lung cancer with diabetes treated with metformin.
Lin JJ; Gallagher EJ; Sigel K; Mhango G; Galsky MD; Smith CB; LeRoith D; Wisnivesky JP
Am J Respir Crit Care Med; 2015 Feb; 191(4):448-54. PubMed ID: 25522257
[TBL] [Abstract][Full Text] [Related]
10. Prediagnosis Smoking Cessation and Overall Survival Among Patients With Non-Small Cell Lung Cancer.
Wang X; Romero-Gutierrez CW; Kothari J; Shafer A; Li Y; Christiani DC
JAMA Netw Open; 2023 May; 6(5):e2311966. PubMed ID: 37145597
[TBL] [Abstract][Full Text] [Related]
11. Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.
Boyer MJ; Williams CD; Harpole DH; Onaitis MW; Kelley MJ; Salama JK
J Thorac Oncol; 2017 Dec; 12(12):1814-1823. PubMed ID: 28951090
[TBL] [Abstract][Full Text] [Related]
12. Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.
Nicoli CD; Sprague BL; Anker CJ; Lester-Coll NH
Am J Clin Oncol; 2019 Jul; 42(7):607-614. PubMed ID: 31232724
[TBL] [Abstract][Full Text] [Related]
13. Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
Popat S; Liu SV; Scheuer N; Gupta A; Hsu GG; Ramagopalan SV; Griesinger F; Subbiah V
JAMA Netw Open; 2022 May; 5(5):e2214046. PubMed ID: 35612853
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.
Chuang MC; Yang YH; Tsai YH; Hsieh MJ; Lin YC; Lin CK; Chen PC; Yang TM
PLoS One; 2018; 13(1):e0191129. PubMed ID: 29329345
[TBL] [Abstract][Full Text] [Related]
15. Association between race and survival of patients with non--small-cell lung cancer in the United States veterans affairs population.
Ganti AK; Subbiah SP; Kessinger A; Gonsalves WI; Silberstein PT; Loberiza FR
Clin Lung Cancer; 2014 Mar; 15(2):152-8. PubMed ID: 24361249
[TBL] [Abstract][Full Text] [Related]
16. Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.
Lin J; Gill A; Zahm SH; Carter CA; Shriver CD; Nations JA; Anderson WF; McGlynn KA; Zhu K
Int J Cancer; 2017 Jul; 141(2):254-263. PubMed ID: 28380674
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.
Löfling L; Karimi A; Sandin F; Bahmanyar S; Kieler H; Lambe M; Lamberg K; Wagenius G
Acta Oncol; 2019 Nov; 58(11):1618-1627. PubMed ID: 31373239
[No Abstract] [Full Text] [Related]
18. Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancer.
West H; Hu X; Zhang S; Song Y; Chirovsky D; Gao C; Lerner A; Jiang A; Signorovitch J; Samkari A
J Manag Care Spec Pharm; 2023 Jul; 29(7):749-757. PubMed ID: 37404067
[No Abstract] [Full Text] [Related]
19. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
20. Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.
Cortellini A; De Giglio A; Cannita K; Cortinovis DL; Cornelissen R; Baldessari C; Giusti R; D'Argento E; Grossi F; Santoni M; Catino A; Berardi R; Sforza V; Rossi G; Antonuzzo L; Di Noia V; Signorelli D; Gelibter A; Occhipinti MA; Follador A; Rastelli F; Chiari R; Gravara LD; Inno A; De Tursi M; Di Marino P; Mansueto G; Zoratto F; Filetti M; Montrone M; Citarella F; Pensieri MV; Russano M; Cantini L; Nigro O; Leonetti A; Bordi P; Minuti G; Landi L; De Toma A; Donisi C; Ricciardi S; Migliorino MR; Napoli VM; Leone G; Metro G; Banna GL; Friedlaender A; Addeo A; Ficorella C; Porzio G
Thorac Cancer; 2021 Mar; 12(6):880-889. PubMed ID: 33527756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
